Department of Neurology, University of California, San Francisco, California 94115, USA.
Neurosurgery. 2012 Aug;71(2):325-30. doi: 10.1227/NEU.0b013e318258e21b.
Treatment with deep brain stimulation (DBS) of the globus pallidus internus in children with DYT1 primary torsion dystonia is highly effective; however, individual response to stimulation is variable, and a greater understanding of predictors of long-term outcome is needed.
To report the long-term outcomes of subjects with young-onset DYT1 primary torsion dystonia treated with bilateral globus pallidus DBS.
Fourteen subjects (7 male, 7 female) treated consecutively from 2000 to 2010 at our center were included in this retrospective study. The Burke-Fahn-Marsden Dystonia Rating Scale was performed at baseline and at 1, 2, and up to 6 years postoperatively.
Pallidal DBS was well tolerated and highly effective, with mean Burke-Fahn-Marsden Dystonia Rating Scale movement scores improving from baseline by 61.5% (P < .001) at 1 year, 64.4% (P < .001) at 2 years, and 70.3% (P < .001) at the final follow-up visit (mean, 32 months; range, 7-77 months). Disability scores also improved significantly. Multiple linear regression analysis revealed a significant influence of duration of disease as a predictor of percent improvement in Burke-Fahn-Marsden Dystonia Rating Scale movement score at long-term follow-up (duration of disease, P < .05). Subjects with fixed orthopedic deformities (4) had less improvement in these regions. Location of the active DBS electrode used at final follow-up visit was not predictive of clinical outcome.
Our findings highlight the sustained benefit from DBS and the importance of early referral for DBS in children with medically refractory DYT1 primary torsion dystonia, which can lead to improved long-term benefits.
深部脑刺激(DBS)治疗 DYT1 原发性扭转痉挛的疗效显著;然而,刺激的个体反应存在差异,需要进一步了解长期预后的预测因素。
报告使用双侧苍白球 DBS 治疗早发性 DYT1 原发性扭转痉挛的患者的长期结果。
本回顾性研究纳入了 2000 年至 2010 年期间在本中心连续接受治疗的 14 名患者(7 名男性,7 名女性)。在基线和术后 1、2 和长达 6 年时进行 Burke-Fahn-Marsden 肌张力障碍评定量表评估。
苍白球 DBS 耐受性良好且效果显著,平均 Burke-Fahn-Marsden 肌张力障碍评定量表运动评分在 1 年时改善 61.5%(P<.001),2 年时改善 64.4%(P<.001),最终随访时改善 70.3%(P<.001)(平均,32 个月;范围,7-77 个月)。残疾评分也显著改善。多线性回归分析显示,疾病持续时间是 Burke-Fahn-Marsden 肌张力障碍评定量表运动评分在长期随访中改善程度的显著预测因素(疾病持续时间,P<.05)。存在固定性骨科畸形的患者(4 例)在这些部位的改善较小。最终随访时使用的活性 DBS 电极的位置与临床结果无预测关系。
我们的研究结果突出了 DBS 的持续获益,以及对于药物难治性 DYT1 原发性扭转痉挛儿童尽早进行 DBS 治疗的重要性,这可以带来长期获益的改善。